Vfend dosing options expand
Executive Summary
Oral suspension form of Pfizer's antifungal Vfend (voriconazole) receives FDA nod Dec. 9. Approval letter says Pfizer will conduct a "two-way drug interaction study between voriconazole and oral contraceptives." Dosage form joins tablets and injection (1"The Pink Sheet" Nov. 24, 2003, In Brief)...
You may also be interested in...
Pfizer Vfend approval
Pfizer's Vfend receives supplemental approval for treatment of esophageal candidiasis Nov. 14. Vfend (voriconazole) was initially approved for primary invasive aspergillosis therapy in May 2002 (1"The Pink Sheet" June 3, 2002, p. 10)...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.